The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease

Peritoneal Dialysis International

Volumn 20, Issue SUPPL. 2, 2000, Pages

  Lameire, Norbert ^a   Van Biesen, Wim ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

First dialysis treatment; Integrative care

Indexed keywords

PERITONEAL DIALYSIS FLUID;

AMYLOIDOSIS; ARTICLE; BIOCOMPATIBILITY; DISEASE COURSE; ECONOMIC EVALUATION; HEMODIALYSIS; HEPATITIS; HUMAN; INFECTION RISK; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NEPHROLOGY; PATIENT REFERRAL; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; SEROCONVERSION; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAFILTRATION; VASCULAR ACCESS;

EID: 0034131398     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002002s26     Document Type: Article

References (113)

1. Popovich R, Moncrief J, Dechard J, Bomar J, Pyle W. The definition of a novel portable/wearable equilibrium dialysis technique [Abstract]. ASAIO Trans 1976; 5:64.
2. Gokal R, Mallick N. Peritoneal dialysis. Lancet 1999; 353:823-8.
3. Lameire N, Van Biesen W, Dombros N, Dratwa M, Faller B, Gahl G, et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 1997; 17(Suppl 2):S161-6.
4. Van Biesen W, Wiedemann M, Lameire N. ESRD treatment: A European perspective. J Am Soc Nephrol 1998; 9(Suppl 1):S55-62.
5. Van Biesen W, voor de LOK groep Nefrologie. Het verwijzingspatroon in Oost en West Vlaanderen van patiënten met terminale nierinsufficiëntie. Tijdschr Geneeskd 1998; 54:1615-21.
6. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, et al. Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993; 8:1089-93.
7. Sesso R, Belasco A. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996; 11:2417-20.
8. Slingeneyer A. Multicenter study on patient referral to dialysis [Abstract]. Perit Dial Int 1998; 18(Suppl 1):S136.
9. Innes A, Rowe P, Burden P, Morgan A. Early deaths on renal replacement therapy: The need for early nephrological referral. Nephrol Dial Transplant 1992; 7:467-71.
10. Campbell J, Ewigman B, Hosokawa M, Van Stone J. The timing of referral of patients with end stage renal disease. Dialysis and Transplantation 1989; 18:660-86.
11. Mendelssohn D, Toh Kua B, Singer P. Referral for dialysis in Ontario. Arch Int Med 1995; 155:2473-8.
12. Hood S, Sondheimer J. Impact of pre-ESRD management on dialysis outcomes: A review. Semin Dial 1998; 11:175-80.
13. McKenzie J, Moss A, Feest T, Stocking C, Siegler M. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis 1998; 31:12-18.
14. United States Renal Data System. 1996 annual data report. Am J Kidney Dis 1996; 28(Suppl 2):S1-165.
15. Kjellstrand C, Hylander B, Collins A. Mortality on dialysis: On the influence of early start, patient characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990; 15:483-90.
16. Ifudu O, Dawood M, Homel P, Friedmann E. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996; 28:841-5.
17. Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant 1998; 13:246-50.
18. Hakim R, Himmelfarb J. Hemodialysis access failure: A call to action. Kidney Int 1998; 54:1029-40.
19. Woods J, Turenne M, Strawderman R, Young E, Hirth R, Port F, et al. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 1997; 30:50-7.
20. Muirhead N, Blyndal K. Potential cost savings of planned dialysis start [Abstract]. J Am Soc Nephrol 1995; 6:553.
21. Levin A, Lewis M, Mortiboy P, Faber S, Hare I, Porter E, et al. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 1997; 29(4):533-40.
22. Garella S. The costs of dialysis in the U.S.A. Nephrol Dial Transplant 1997; 12(Suppl 1):10-21.
23. Jacobs C. The costs of dialysis treatments for patients with end stage renal disease in France. Nephrol Dial Transplant 1997; 12(Suppl 1):29-32.
24. Rasgon S, Chemleski B, Ho S, Widrow L, Yeoh H, Schwanskowsky L, et al. Benefits of a multidisciplinary predialysis program in maintaining employment among patients on home dialysis. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12:132-5.
25. Clyne N, Björvell H, Klang B, Sundstedt C. Patient education in groups in the predialysis stage results in better adaptation to dialysis [Abstract]. J Am Soc Nephrol 1996; 7:1442.
26. Hakim R, Lazarus J. Initiation of dialysis. J Am Soc Nephrol 1995; 6:1319-28.
27. Ahlmen J, Carlsson L, Schönborg C. Well-informed patients with end stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int 1993; 13(Suppl 2):S196-8.
28. Coles G, Williams J. What is the place of peritoneal dialysis in the integrated treatment of renal failure? Kidney Int 1998; 54:2234-40.
29. Rottembourg J, Issad B, Gallego J, Degoulet P, Aime F, Gueffaf B, et al. Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 19:397-403.
30. Lysaght M. Preservation of residual renal function in maintenance dialysis patients. Perit Dial Int 1996; 16:126-7.
31. Lameire N. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 1997; 77:13-28.
32. Lameire N, Van Biesen W. The impact of residual renal function on the adequacy of peritoneal dialysis. Perit Dial Int 1997; 17(Suppl 2):S102-10.
33. Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
34. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48:1946-52.
35. Catizone L, Viglietta G, Cocchi R, Dadone C, De Vecchi A, Giangrande A, et al. Dialysis-related amyloidosis in a large CAPD population. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:213-17.
36. DiRaimondo CR, Mccarley P, Stone WJ. Beta-2 microglobulin in peritoneal dialysis patients: Serum levels and peritoneal clearances. Perit Dial Int 1988; 8:43-7.
37. 2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. Kidney Int 1998; 54:956-9.
38. Lopez-Menchero R, Miguel A, Garcia-Ramon R, Perez-Contreras J, Girbes V. Importance of residual renal function in continuous ambulatory peritoneal dialysis: Its influence on different parameters of renal replacement treatment. Nephron 1999; 83:219-25.
39. Niwa T, Ise M. Indoxyl sulphate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124:96-104.
40. Niwa T, Yazawa T, Kodama T, Uehara Y, Maeda K, Yamada K. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 1990; 56:241-5.
41. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, et al. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991; 40:461-9.
42. Blake P. Adequacy, nutrition, and clinical outcomes. Perit Dial Int 1999; 19(Suppl 2):S16-19.
43. Oreopoulos D. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int 1999; 55:1131-49.
44. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A. Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 1996; 16:307-15.
45. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 1999; 14:1224-8.
46. McCarthy J. The use of polysulphone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients [Abstract]. J Am Soc Nephrol 1993; 4:367.
47. Lysaght M, Vonesh E, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37:598-604.
48. Davies S, Phillips L, Russell G. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
49. Mujais S, Mayber N, Schulz D, Hutchcraft A. Timely initiation of dialysis by DOQI guidelines: Maintenance of residual renal function. Kidney Int 1999; 10:265A.
50. Van Biesen W, Vanholder R, Lameire N. Impact of pretransplantation dialysis modality on patient outcome after renal transplantation: The role of peritoneal dialysis revisited. Perit Dial Int 1999; 19:103-6.
51. Bleyer A, Burkart J, Russell G, Adams P. Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 1999; 10:154-9.
52. Perez Fontan MP, Rodriguez-Carmona A, Garcia Falcon T, Moncalian J, Oliver J, Valdes F. Renal transplantation in patients undergoing chronic peritoneal dialysis. Perit Dial Int 1996; 16:48-51.
53. Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54:972-8.
54. Samaniego M, Baldwin W, Sanfilippo F. Delayed graft function: Immediate and late impact. Curr Opin Nephrol Hypertens 1997; 6:533-7.
55. Passalacqua JA, Wiland AM, Fink JC, Bartlett ST, Evans DA, Keay S. Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients. Transplantation 1999; 68:535-40.
56. Pereira B, Levey A. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51:981-99.
57. Parfrey P, Forbes R, Hutchinson T. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1987; 39:369-76.
58. Cendoroglo M, Draibe S, Silva A, Ferraz M, Granato C, Pereira C, et al. Incidence and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 1995; 10:240-6.
59. Pascual J, Teruel J, Mateos M. Nosocomial transmission of hepatitis C virus infection in a hemodialysis unit during two years of prospective follow-up [Abstract]. J Am Soc Nephrol 1992; 3:386.
60. Jadoul M, Chantal C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis seroconversion in hemodialysis: A prospective study. Kidney Int 1993; 44:1322-6.
61. Stuyver L, Claeys H, Wyseur A, Van Arnhem W, De Beenhouwer H, Uytendaele S, et al. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int 1996; 49:889-95.
62. Miller E, Alter M, Tokars J. Protective effects of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999; 33:356-60.
63. Khan A, Bernardini J, Rault R, Piraino B. Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Perit Dial Int 1996; 16:370-3.
64. Nomoto Y, Kawaguchi Y, Ohira S, Yuri T, Kubo H, Kubota M, et al. Carpal tunnel syndrome in patients undergoing CAPD: A collaborative study in 143 centers. Am J Nephrol 1995; 15:295-9.
65. 2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1999; 14:1467-71.
66. Fan P, Schwab S. Vascular access: Concepts for the 1990s. J Am Soc Nephrol 1992; 3:1-11.
67. Ifudu O, Mayers J, Cohen L, Paul H, Brezsnyak W, Avram M, et al. Correlates of vascular access and non-vascular access related hospitalizations in hemodialysis patients. Am J Nephrol 1996; 16:118-23.
68. De Vecchi A, Dratwa M, Wiedemann M. Healthcare systems and end stage renal disease therapies: An international review. Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14(Suppl 6):31-41.
69. Van Biesen W, Vanholder R, Dhondt AM, Veys N, Lameire N. An evaluation of an integrative care approach for the treatment of ESRD patients. J Am Soc Nephrol 2000; 11:116-25.
70. Van Biesen W, Dequidt C, Vijt D, Vanholder R, Lameire N. Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1998; 14:90-4.
71. Maiorca R, Cancarini G, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int 1996; 16:276-87.
72. Burton PR, Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis and transplantation. Lancet 1987; 1(8542):1115-19.
73. Lee HB, Song KI, Kim JH, Cha MK, Park MS. Dialysis in patients with diabetic nephropathy: CAPD versus hemodialysis. Perit Dial Int 1996; 16(Suppl 1):S269-74.
74. Marcelli D, Stannard D, Conte F, Held P, Locatelli F, Port F. ESRD patient mortality with adjustment for comorbid conditions in Lombardy versus the United States. Kidney Int 1996; 50:1013-18.
75. Gentil M, Carriazo A, Pavon M, Rosado M, Castillo D, Ramos B, et al. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital hemodialysis: A multicentric study. Nephrol Dial Transplant 1991; 6:444-51.
76. Serkes K, Blagg C, Nolph K, Vonesh E, Shapiro F. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis and hemodialysis: A multicenter study. Perit Dial Int 1990; 10:15-19.
77. Maiorca R, Cancarini G, Camerini C, Brunori G, Manili L, Movilli E, et al. Is CAPD competitive with hemodialysis for long-term treatment of uraemic patients? Nephrol Dial Transplant 1989; 4:244-53.
78. Maiorca R, Vonesh E, Cancarini G, Cantaluppi A, Manili L, Brunori G, et al. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988; 34:518-24.
79. Gokal R, Baillod R, Bogle S, Hunt L, Jacubowski C, Marsh F, et al. Multi-center study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and hemodialysis. Nephrol Dial Transplant 1987; 2:172-8.
80. Held P, Pauly M, Diamond L. Survival analysis of patients undergoing dialysis. JAMA 1987; 257:645-50.
81. Held P, Port F, Turenne M, Gaylin D, Hamburger R, Wolfe R. Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45:1163-9.
82. Gokal R, King J, Bogle S, Marsh F, Oliver D, Jakubowski C, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4-year analysis of a prospective multi-center study. Lancet 1987; 2(8568):1105-9.
83. Port F, Wolfe R, Bloembergen W, Held P, Young E. The study of outcomes for CAPD versus hemodialysis patients. Perit Dial Int 1996; 16:628-33.
84. Bloembergen W, Port F, Mauger E, Wolfe R. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
85. Foley R, Parfrey P, Harnett J, Kent G, O'Dea R, Murray D, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9:267-76.
86. Vonesh E, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10:354-65.
87. Fenton S, Schaubel D, Desmeules M, Morrison H, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
88. Davies S, Phillips L, Griffiths A, Russell L, Naish P, Russell G. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
89. Canaud B, Mion C. Place de la dialyse péritonéale continue ambulatoire au sein d'un programme de traitement de l'insuffisance rénale chronique. Problèmes posés par les transferts de DCPA en transplantation ou en hémodialyse. Nephrologie 1995; 16:129-35.
90. Singh S, Yium J, Macon E, Clark E, Schaffer D, Teschan P. Multicenter study of change in dialysis therapy: Maintenance hemodialysis to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 19:246-51.
91. Diaz-Buxo JA, Gotch FA, Folden TI, Rosenblum S, Zazra J, Lew N, et al. Peritoneal dialysis adequacy: A model to assess feasibility with various modalities. Kidney Int 1999; 55:2493-501.
92. Woodrow G, Turney J, Brownjohn A. Technique failure im peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17:360-4.
93. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34:1065-74.
94. Khan I. Survival on renal replacement therapy in Europe: Is there a "center effect"? Nephrol Dial Transplant 1996; 11:300-7.
95. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998; 10:1956-64.
96. Topley N. Biocompatibility of peritoneal dialysis solutions and host defense. Adv Ren Replace Ther 1996; 3:309-11.
97. Coles GA. Biocompatibility of various osmotic solutes. Perit Dial Int 1995; 15(Suppl 1):S71-5.
98. Lameire N, Matthys D, Matthys E, Beheydt R, Ringoir S. Effects of longterm CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30:853-8.
99. Vanholder R, Lameire N, Waterloos MA, Van Landschoot N, De Smet R, Vogeleere P, et al. Disturbed host defense in peritoneal cavity during CAPD: Characterization of responsible factors in dwell fluid. Kidney Int 1996; 50:643-52.
100. Schambye H. Effect of different buffers on the biocompatibility of CAPD solutions. Perit Dial Int 1996; 16(Suppl 1):S130-6.
101. Krediet RT, Douma CE, Ho-dac-Pannekeet MM, Imholz AL, Zemel D, Zweers MM, et al. Impact of different dialysis solutions on solute and water transport. Perit Dial Int 1997; 17(Suppl 1):S17-26.
102. Vanholder RC, Lameire NH. Osmotic agents in peritoneal dialysis. Kidney Int 1996; 50(Suppl 56):S86-91.
103. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 1997; 17:144-50.
104. Hendriks PMEM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SSKS, Sie L, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
105. Van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschraegen G, Vijt D, et al. The need for a center-tailored treatment protocol for peritonitis. Perit Dial Int 1998; 18:274-81.
106. International Society for Peritoneal Dialysis, Advisory Committee on Peritonitis Management. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
107. Van Biesen W, Vanholder R, Lameire N. Recent developments in osmotic agents for peritoneal dialysis. Adv Ren Replace Ther 1998; 5:218-31.
108. Lameire N, Van Biesen W, Vanholder R. Consequences of using glucose as osmotic agent for peritoneal dialysis. Semin Dial 1998; 11:271-5.
109. Lamb EJ, Cattell WR, Dawnay AB. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1997; 47:1768-74.
110. Dawnay AB, Millar DJ. Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int 1997; 17:21-8.
111. Krediet RT, Zweers MM, Ho-dac-Pannekeet MM, van der Wal AC, Smit W, Douma CE, et al. The effect of various dialysis solutions on peritoneal membrane viability. Perit Dial Int 1999; 19(Suppl 2):S257-66.
112. Van Biesen W, Faict D, Boer W, Lameire N. Further animal and human experience with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution. Perit Dial Int 1997; 17(Suppl 2):S56-62.
113. Lameire N, Van Biesen W, Van Landschoot M, Wang T, Heimbürger O, Bergström J, et al. Experimental models in peritoneal dialysis: A European experience. Kidney Int 1998; 54:2194-206.